Free Trial

Lixte Biotechnology (LIXT) Short Interest Ratio & Short Volume

$2.58
+0.16 (+6.61%)
(As of 06/12/2024 ET)

Lixte Biotechnology Short Interest Data

Current Short Interest
12,100 shares
Previous Short Interest
16,100 shares
Change Vs. Previous Month
-24.84%
Dollar Volume Sold Short
$28,291.01
Short Interest Ratio
0.0 Days to Cover
Last Record Date
May 31, 2024
Outstanding Shares
2,250,000 shares
Float Size
1,800,000 shares
Short Percent of Float
0.67%
Today's Trading Volume
5,963 shares
Average Trading Volume
322,770 shares
Today's Volume Vs. Average
2%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Lixte Biotechnology ?

Sign up to receive the latest short interest report for Lixte Biotechnology and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LIXT Short Interest Over Time

LIXT Days to Cover Over Time

LIXT Percentage of Float Shorted Over Time

Lixte Biotechnology Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/202412,100 shares $28,291.01 -24.8%0.7%0 $2.34
5/15/202416,100 shares $36,869.00 -31.8%0.9%0 $2.29
4/30/202423,600 shares $68,204.00 -71.5%1.3%0 $2.89
4/15/202482,700 shares $272,910.00 +395.2%4.6%0.2 $3.30
3/31/202416,700 shares $56,446.00 -14.8%1.0%0 $3.38
3/15/202419,600 shares $45,276.00 -62.3%1.1%0.5 $2.31
2/29/202452,000 shares $135,200.00 +258.6%3.0%1.4 $2.60
2/15/202414,500 shares $39,440.00 +42.2%0.8%0.3 $2.72
1/31/202410,200 shares $21,063.00 +117.0%0.6%0.4 $2.07
1/15/20244,700 shares $9,118.00 -63.0%0.3%0.1 $1.94
12/31/202312,700 shares $29,845.00 -32.5%0.7%0.3 $2.35
12/15/202318,800 shares $39,668.00 -26.0%1.1%0.4 $2.11
11/30/202325,400 shares $59,182.00 -60.1%1.5%0.5 $2.33
11/15/202363,700 shares $184,730.00 +295.7%3.7%1.2 $2.90
10/31/202316,100 shares $38,720.50 -1.8%0.9%0.4 $2.41
10/15/202316,400 shares $39,360.00 -44.6%1.0%0.3 $2.40
9/30/202329,600 shares $72,520.00 +261.0%2.1%0.2 $2.45
9/15/20238,200 shares $17,384.00 +13.9%0.6%0.1 $2.12
8/31/20237,200 shares $18,036.00 -44.2%0.3%0.1 $2.51
8/15/202312,900 shares $32,250.00 -84.3%0.6%0.1 $2.50
7/31/202382,200 shares $289,344.00 +774.5%4.7%0.6 $3.52
7/15/20239,400 shares $51,042.00 +8.1%1.0%0.1 $5.43
6/30/20238,700 shares $50,721.00 -28.7%0.5%0.4 $5.83
6/15/202312,200 shares $57,950.00 +306.7%1.5%0.7 $4.75
5/31/20233,000 shares $20,784.00 -86.2%0.4%0.3 $6.93
5/15/202321,800 shares $14,483.92 +162.7%0.3%0.2 $0.66
4/30/20238,300 shares $4,656.30 -80.0%0.1%0 $0.56
4/15/202341,500 shares $26,153.30 -45.8%0.5%0 $0.63
3/31/202376,500 shares $63,288.45 -39.1%1.0%0.1 $0.83
3/15/2023125,700 shares $85,853.10 +31.5%1.7%0.1 $0.68
2/28/202395,600 shares $86,757.00 -38.7%1.3%0.1 $0.91
2/15/2023156,000 shares $180,960.00 +459.1%2.1%0.1 $1.16
1/31/202327,900 shares $22,041.00 -62.6%0.4%0 $0.79
1/15/202374,500 shares $42,465.00 +89.1%1.0%2 $0.57
12/30/202239,400 shares $20,054.60 -7.9%0.5%1.2 $0.51
12/15/202242,800 shares $23,171.92 -15.9%0.6%1.7 $0.54
11/30/202250,900 shares $38,938.50 +53.3%0.7%1.8 $0.77
11/15/202233,200 shares $18,283.24 +26.7%0.5%1.1 $0.55
10/31/202226,200 shares $13,105.24 +5.2%0.4%0.5 $0.50
10/15/202224,900 shares $12,980.37 -58.5%0.4%0.2 $0.52
Estee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI company (Ad)

A Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.

Discover this unknown NYSE Tech SaaS company
9/30/202260,000 shares $33,612.00 +64.4%0.9%0.5 $0.56
9/15/202236,500 shares $25,761.70 -43.4%0.5%0.3 $0.71
8/31/202264,500 shares $50,310.00 -30.0%0.9%0.5 $0.78
8/15/202292,100 shares $74,582.58 +435.5%1.3%0.6 $0.81
7/31/202217,200 shares $12,934.40 -27.4%0.2%0.1 $0.75
7/15/202223,700 shares $19,434.00 +0.9%0.3%0 $0.82
6/30/202223,500 shares $17,496.93 -20.3%0.3%0 $0.74
6/15/202229,500 shares $21,537.95 -38.3%0.4%0 $0.73
5/31/202247,800 shares $35,873.90 -12.3%0.7%0 $0.75
5/15/202254,500 shares $51,824.05 -59.9%0.8%0 $0.95
4/30/2022136,000 shares $160,480.00 -92.4%2.7%0 $1.18
4/15/20221,800,000 shares $2.83 million +10,614.3%35.2%0.6 $1.57
3/31/202216,800 shares $20,664.00 +8.4%0.4%0.1 $1.23
3/15/202215,500 shares $17,050.00 -59.2%0.3%0 $1.10
2/28/202238,000 shares $53,960.00 -9.5%0.7%0 $1.42
2/15/202242,000 shares $68,460.00 -66.0%0.7%0 $1.63
1/31/2022123,600 shares $239,784.00 -62.3%2.2%0.1 $1.94
1/15/2022328,200 shares $643,272.00 +589.5%5.8%0.2 $1.96
12/31/202147,600 shares $56,644.00 +14.2%0.8%0 $1.19
12/15/202141,700 shares $57,963.00 +110.6%0.7%0.8 $1.39
11/30/202119,800 shares $32,274.00 -54.2%0.4%0.4 $1.63
11/15/202143,200 shares $78,192.00 -20.2%0.8%0.9 $1.81
10/29/202154,100 shares $101,708.00 +0.4%1.0%0.7 $1.88
10/15/202153,900 shares $100,793.00 +11.4%1.0%0.1 $1.87
9/30/202148,400 shares $100,672.00 +25.4%0.9%0.1 $2.08
9/15/202138,600 shares $84,148.00 +196.9%0.7%0.1 $2.18
8/31/202113,000 shares $31,980.00 -80.7%0.2%0 $2.46
8/13/202167,400 shares $150,976.00 +2,006.3%1.2%0.2 $2.24
7/30/20213,200 shares $8,800.00 -82.4%0.1%0 $2.75
7/15/202118,200 shares $54,418.00 -37.5%0.3%0.1 $2.99
6/30/202129,100 shares $88,173.00 +193.9%0.5%0.1 $3.03
6/15/20219,900 shares $29,304.00 -66.9%0.2%0 $2.96
5/28/202129,900 shares $81,926.00 +81.2%0.5%0.1 $2.74
5/14/202116,500 shares $42,817.50 -45.7%0.3%0 $2.60
4/30/202130,400 shares $87,856.00 +98.7%0.5%0 $2.89
4/15/202115,300 shares $45,441.00 -62.7%0.3%0 $2.97
3/31/202141,000 shares $132,020.00 +151.5%1.0%0 $3.22
3/15/202116,300 shares $71,231.00 -13.8%0.4%0 $4.37
2/26/202118,900 shares $71,253.00 +575.0%0.5%0 $3.77
2/12/20212,800 shares $10,220.00 +64.7%0.1%0 $3.65
1/29/20211,700 shares $5,346.50 -15.0%0.1%0 $3.15
1/15/20212,000 shares $6,520.00 No Change0.1%0 $3.26
11/15/20208,400 shares $9,492.00 +140.0%N/A2.8 $1.13
10/30/20203,500 shares $3,920.00 +2.9%N/A3.9 $1.12
10/15/20203,400 shares $3,910.00 +17.2%N/A2.1 $1.15
9/30/20202,900 shares $3,393.00 +107.1%N/A1.4 $1.17
9/15/20201,400 shares $1,400.00 +40.0%N/A0.1 $1.00
8/31/20201,000 shares $1,180.00 -9.1%N/A0.3 $1.18
8/14/20201,100 shares $1,298.00 +37.5%N/A0.7 $1.18
7/31/2020800 shares $952.00 -84.0%N/A0.1 $1.19
Estee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI company (Ad)

A Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.

Discover this unknown NYSE Tech SaaS company
7/15/20205,000 shares $4,400.00 -2.0%N/A1.4 $0.88
6/30/20205,100 shares $4,590.00 +13.3%N/A3 $0.90
6/15/20204,500 shares $4,050.00 +12.5%N/A3.2 $0.90
5/29/20204,000 shares $3,520.00 No ChangeN/A1 $0.88
5/15/20204,000 shares $3,600.00 -36.5%N/A1.1 $0.90
4/30/20206,300 shares $5,607.00 +26.0%N/A2.4 $0.89
4/15/20205,000 shares $5,000.00 +284.6%N/A0.9 $1.00
3/31/20201,300 shares $1,274.00 +225.0%N/A0.3 $0.98
3/13/2020400 shares $355.60 No ChangeN/A0.2 $0.89
2/28/2020400 shares $368.00 -66.7%N/A0 $0.92
2/14/20201,200 shares $1,068.00 +50.0%N/A0.1 $0.89
1/31/2020800 shares $599.92 No ChangeN/A0.2 $0.75
1/15/2020800 shares $551.20 +100.0%N/A0.3 $0.69
12/31/2019400 shares $280.00 -86.7%N/A0 $0.70

LIXT Short Interest - Frequently Asked Questions

What is Lixte Biotechnology's current short interest?

Short interest is the volume of Lixte Biotechnology shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 12,100 shares of LIXT short. 0.67% of Lixte Biotechnology's shares are currently sold short. Learn More on Lixte Biotechnology's current short interest.

What is a good short interest percentage for Lixte Biotechnology?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.67% of Lixte Biotechnology's floating shares are currently sold short.

Is Lixte Biotechnology's short interest increasing or decreasing?

Lixte Biotechnology saw a decline in short interest in the month of May. As of May 31st, there was short interest totaling 12,100 shares, a decline of 24.8% from the previous total of 16,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Lixte Biotechnology's float size?

Lixte Biotechnology currently has issued a total of 2,250,000 shares. Some of Lixte Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lixte Biotechnology currently has a public float of 1,800,000 shares.

How does Lixte Biotechnology's short interest compare to its competitors?

0.67% of Lixte Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lixte Biotechnology: KALA BIO, Inc. (0.32%), Synlogic, Inc. (0.12%), Akari Therapeutics, Plc (0.27%), Jaguar Health, Inc. (7.22%), VBI Vaccines Inc. (1.13%), Aytu BioPharma, Inc. (8.65%), GlycoMimetics, Inc. (3.24%), Talphera, Inc. (1.00%), Sensei Biotherapeutics, Inc. (1.72%), Orgenesis Inc. (0.60%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short Lixte Biotechnology stock?

Short selling LIXT is an investing strategy that aims to generate trading profit from Lixte Biotechnology as its price is falling. LIXT shares are trading up $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lixte Biotechnology?

A short squeeze for Lixte Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LIXT, which in turn drives the price of the stock up even further.

How often is Lixte Biotechnology's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LIXT, twice per month. The most recent reporting period available is May, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:LIXT) was last updated on 6/13/2024 by MarketBeat.com Staff

From Our Partners